Essex Investment Management’s Q32 Bio QTTB Stock Holding History

Essex Investment Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-421	Closed	-$169K	–	515
2018 Q4	$169K	Buy	+421	New	+$159K	0.03%	352

Other funds holding QTTB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VV Manager Boston, Massachusetts $114M AUM 59.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Essex Investment Management's QTTB Position: Q1 2019 in Review

Essex Investment Management sold out of Q32 Bio (QTTB) in Q1 2019, closing a stake of 421 shares — an estimated $169K sold.

Essex Investment Management first reported a position in QTTB in Q4 2018 and held it in 1 quarter. The position peaked at $169K in Q4 2018. 66 funds tracked by Wall St. Rank hold QTTB as of Q1 2019.

Essex Investment Management reported no remaining Q32 Bio position as of Q1 2019 after selling out during the quarter.
Essex Investment Management sold 421 Q32 Bio shares in Q1 2019, an estimated $169K.
Essex Investment Management first reported a position in Q32 Bio in Q4 2018 and held it in 1 quarter.
Essex Investment Management's Q32 Bio position peaked at $169K in Q4 2018.
66 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2019.

Based on Essex Investment Management's 13F filing for Q1 2019, filed 15 May 2019.